ParkinsonFranceV1, Istex, Corpus, bibRecord, 000102

5-HT3 receptors and cytotoxic drug-induced vomiting

Identifieur interne : 000102 ( Istex/Corpus ); précédent : 000101; suivant : 000103

5-HT3 receptors and cytotoxic drug-induced vomiting

Auteurs : J. R. Fozard

Source :

Trends in Pharmacological Sciences [ 0165-6147 ] ; 1987.

RBID : ISTEX:8AD96E6AC773C72735A7E56CF389FBA851203ECC
Url:

https://api.istex.fr/document/8AD96E6AC773C72735A7E56CF389FBA851203ECC/fulltext/pdf

DOI: 10.1016/0165-6147(87)90002-2

Links to Exploration step

ISTEX:8AD96E6AC773C72735A7E56CF389FBA851203ECC

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>5-HT3 receptors and cytotoxic drug-induced vomiting</title>
<author><name sortKey="Fozard, J R" sort="Fozard, J R" uniqKey="Fozard J" first="J. R." last="Fozard">J. R. Fozard</name>
<affiliation><mods:affiliation>Merrell Dow Research Institute, 16 Rue d'Ankara, 67084 Strasbourg Cedex, France</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:8AD96E6AC773C72735A7E56CF389FBA851203ECC</idno>
<date when="1987" year="1987">1987</date>
<idno type="doi">10.1016/0165-6147(87)90002-2</idno>
<idno type="url">https://api.istex.fr/document/8AD96E6AC773C72735A7E56CF389FBA851203ECC/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000102</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000102</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">5-HT3 receptors and cytotoxic drug-induced vomiting</title>
<author><name sortKey="Fozard, J R" sort="Fozard, J R" uniqKey="Fozard J" first="J. R." last="Fozard">J. R. Fozard</name>
<affiliation><mods:affiliation>Merrell Dow Research Institute, 16 Rue d'Ankara, 67084 Strasbourg Cedex, France</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Trends in Pharmacological Sciences</title>
<title level="j" type="abbrev">TIPS</title>
<idno type="ISSN">0165-6147</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1987">1987</date>
<biblScope unit="volume">8</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="44">44</biblScope>
<biblScope unit="page" to="45">45</biblScope>
</imprint>
<idno type="ISSN">0165-6147</idno>
</series>
<idno type="istex">8AD96E6AC773C72735A7E56CF389FBA851203ECC</idno>
<idno type="DOI">10.1016/0165-6147(87)90002-2</idno>
<idno type="PII">0165-6147(87)90002-2</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0165-6147</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<istex><corpusName>elsevier</corpusName>
<author><json:item><name>J.R. Fozard</name>
<affiliations><json:string>Merrell Dow Research Institute, 16 Rue d'Ankara, 67084 Strasbourg Cedex, France</json:string>
</affiliations>
</json:item>
</author>
<subject><json:item><lang><json:string>eng</json:string>
</lang>
<value>NMS : N-methylscopolamine AF-DX 116(11[[2-[(diethylamino)methyl]-1-piperidinyljacetyl]-5</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>11-dihydro-6H-pyrido[2</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>3–6][1</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>4]benzodiazepine-6-)one 4-DAMP : 4-diphenylacetoxy- N -methyl piperidine methiodide DFP diisopropylfluorophosphate</value>
</json:item>
</subject>
<language><json:string>eng</json:string>
</language>
<originalGenre><json:string>Short communication</json:string>
</originalGenre>
<qualityIndicators><score>1.327</score>
<pdfVersion>1.2</pdfVersion>
<pdfPageSize>576 x 792 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<keywordCount>4</keywordCount>
<abstractCharCount>0</abstractCharCount>
<pdfWordCount>1315</pdfWordCount>
<pdfCharCount>9329</pdfCharCount>
<pdfPageCount>2</pdfPageCount>
<abstractWordCount>1</abstractWordCount>
</qualityIndicators>
<title>5-HT3 receptors and cytotoxic drug-induced vomiting</title>
<pii><json:string>0165-6147(87)90002-2</json:string>
</pii>
<refBibs><json:item><host><volume>25</volume>
<pages><last>73</last>
<first>63</first>
</pages>
<issue>Suppl. 1</issue>
<author></author>
<title>Drugs</title>
</host>
</json:item>
<json:item><host><volume>25</volume>
<pages><last>494</last>
<first>451</first>
</pages>
<author></author>
<title>Drugs</title>
</host>
</json:item>
<json:item><host><volume>70</volume>
<pages><last>641</last>
<first>637</first>
</pages>
<author></author>
<title>Cancer Treat. Rep.</title>
</host>
</json:item>
<json:item><host><volume>25</volume>
<pages><last>51</last>
<first>35</first>
</pages>
<issue>Suppl. 1</issue>
<author></author>
<title>Drugs</title>
</host>
</json:item>
<json:item><host><volume>25</volume>
<pages><last>576</last>
<first>563</first>
</pages>
<author></author>
<title>Neuropharmacology</title>
</host>
</json:item>
<json:item><host><pages><last>56</last>
<first>37</first>
</pages>
<author></author>
<title>Proc. 3rd SCI-RSC Medicinal Chemistry Symposium</title>
</host>
</json:item>
<json:item><host><volume>9</volume>
<pages><last>428</last>
<first>424</first>
</pages>
<author></author>
<title>Trends Neurosci.</title>
</host>
</json:item>
<json:item><host><volume>49</volume>
<pages><last>112</last>
<first>109</first>
</pages>
<author></author>
<title>Eur. J. Pharmacol.</title>
</host>
</json:item>
<json:item><host><pages><last>307</last>
<first>295</first>
</pages>
<author></author>
<title>Advances in Neurology</title>
</host>
</json:item>
<json:item><host><volume>88</volume>
<pages><first>374P</first>
</pages>
<author></author>
<title>Br. J. Pharmacol.</title>
</host>
</json:item>
<json:item><host><volume>88</volume>
<pages><last>499</last>
<first>497</first>
</pages>
<author></author>
<title>Br. J. Pharmacol.</title>
</host>
</json:item>
<json:item><host><volume>66</volume>
<pages><last>189</last>
<first>187</first>
</pages>
<author></author>
<title>Cancer Treat. Rep.</title>
</host>
</json:item>
<json:item><host><volume>25</volume>
<pages><last>961</last>
<first>959</first>
</pages>
<author></author>
<title>Neuropharmacology</title>
</host>
</json:item>
<json:item><host><volume>3</volume>
<pages><first>139</first>
</pages>
<author></author>
<title>Rev. Farmacol. Clin. Exp.</title>
</host>
</json:item>
<json:item><host><volume>326</volume>
<pages><last>44</last>
<first>36</first>
</pages>
<author></author>
<title>Naunyn-Schmied. Arch. Pharmacol.</title>
</host>
</json:item>
<json:item><host><volume>25</volume>
<pages><last>7</last>
<first>1</first>
</pages>
<issue>Suppl. 1</issue>
<author></author>
<title>Drugs</title>
</host>
</json:item>
<json:item><host><pages><last>48</last>
<first>24</first>
</pages>
<author></author>
<title>Drug and Therapeutics Bulletin</title>
</host>
</json:item>
</refBibs>
<genre><json:string>brief-communication</json:string>
</genre>
<host><volume>8</volume>
<pii><json:string>S0165-6147(00)X0133-2</json:string>
</pii>
<pages><last>45</last>
<first>44</first>
</pages>
<issn><json:string>0165-6147</json:string>
</issn>
<issue>2</issue>
<genre><json:string>journal</json:string>
</genre>
<language><json:string>unknown</json:string>
</language>
<title>Trends in Pharmacological Sciences</title>
<publicationDate>1987</publicationDate>
</host>
<categories><wos><json:string>science</json:string>
<json:string>pharmacology & pharmacy</json:string>
</wos>
<scienceMetrix><json:string>health sciences</json:string>
<json:string>clinical medicine</json:string>
<json:string>pharmacology & pharmacy</json:string>
</scienceMetrix>
</categories>
<publicationDate>1987</publicationDate>
<copyrightDate>1987</copyrightDate>
<doi><json:string>10.1016/0165-6147(87)90002-2</json:string>
</doi>
<id>8AD96E6AC773C72735A7E56CF389FBA851203ECC</id>
<score>0.15378672</score>
<fulltext><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/document/8AD96E6AC773C72735A7E56CF389FBA851203ECC/fulltext/pdf</uri>
</json:item>
<json:item><extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/document/8AD96E6AC773C72735A7E56CF389FBA851203ECC/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/8AD96E6AC773C72735A7E56CF389FBA851203ECC/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a">5-HT3 receptors and cytotoxic drug-induced vomiting</title>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher>ELSEVIER</publisher>
<availability><p>ELSEVIER</p>
</availability>
<date>1987</date>
</publicationStmt>
<notesStmt><note type="content">Section title: Current awareness</note>
</notesStmt>
<sourceDesc><biblStruct type="inbook"><analytic><title level="a">5-HT3 receptors and cytotoxic drug-induced vomiting</title>
<author xml:id="author-1"><persName><forename type="first">J.R.</forename>
<surname>Fozard</surname>
</persName>
<note type="biography">Present address: Preclinical Research Department, Sandoz AG, CH4002, Basel, Switzerland.</note>
<affiliation>Present address: Preclinical Research Department, Sandoz AG, CH4002, Basel, Switzerland.</affiliation>
<affiliation>Merrell Dow Research Institute, 16 Rue d'Ankara, 67084 Strasbourg Cedex, France</affiliation>
</author>
</analytic>
<monogr><title level="j">Trends in Pharmacological Sciences</title>
<title level="j" type="abbrev">TIPS</title>
<idno type="pISSN">0165-6147</idno>
<idno type="PII">S0165-6147(00)X0133-2</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1987"></date>
<biblScope unit="volume">8</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="44">44</biblScope>
<biblScope unit="page" to="45">45</biblScope>
</imprint>
</monogr>
<idno type="istex">8AD96E6AC773C72735A7E56CF389FBA851203ECC</idno>
<idno type="DOI">10.1016/0165-6147(87)90002-2</idno>
<idno type="PII">0165-6147(87)90002-2</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><creation><date>1987</date>
</creation>
<langUsage><language ident="en">en</language>
</langUsage>
<textClass><keywords scheme="keyword"><list><head>Abbreviations</head>
<item><term>NMS</term>
<term>N-methylscopolamine AF-DX 116(11[[2-[(diethylamino)methyl]-1-piperidinyljacetyl]-5</term>
</item>
<item><term>11-dihydro-6H-pyrido[2</term>
</item>
<item><term>3–6][1</term>
</item>
<item><term>4]benzodiazepine-6-)one 4-DAMP</term>
<term>4-diphenylacetoxy- N -methyl piperidine methiodide DFP diisopropylfluorophosphate</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc><change when="1987">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/document/8AD96E6AC773C72735A7E56CF389FBA851203ECC/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="Elsevier, elements deleted: tail"><istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType>
<istex:document><converted-article version="4.5.2" docsubtype="sco"><item-info><jid>TIPS</jid>
<aid>87900022</aid>
<ce:pii>0165-6147(87)90002-2</ce:pii>
<ce:doi>10.1016/0165-6147(87)90002-2</ce:doi>
<ce:copyright type="unknown" year="1987"></ce:copyright>
</item-info>
<head><ce:dochead><ce:textfn>Current awareness</ce:textfn>
</ce:dochead>
<ce:title>5-HT<ce:inf>3</ce:inf>
 receptors and cytotoxic drug-induced vomiting</ce:title>
<ce:author-group><ce:author><ce:given-name>J.R.</ce:given-name>
<ce:surname>Fozard</ce:surname>
<ce:cross-ref refid="FN1"><ce:sup>∗</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:affiliation><ce:textfn>Merrell Dow Research Institute, 16 Rue d'Ankara, 67084 Strasbourg Cedex, France</ce:textfn>
</ce:affiliation>
<ce:footnote id="FN1"><ce:label>∗</ce:label>
<ce:note-para>Present address: Preclinical Research Department, Sandoz AG, CH4002, Basel, Switzerland.</ce:note-para>
</ce:footnote>
</ce:author-group>
<ce:keywords class="abr"><ce:section-title>Abbreviations</ce:section-title>
<ce:keyword><ce:text>NMS</ce:text>
<ce:keyword><ce:text>N-methylscopolamine AF-DX 116(11[[2-[(diethylamino)methyl]-1-piperidinyljacetyl]-5</ce:text>
</ce:keyword>
</ce:keyword>
<ce:keyword><ce:text>11-dihydro-6H-pyrido[2</ce:text>
</ce:keyword>
<ce:keyword><ce:text>3–6][1</ce:text>
</ce:keyword>
<ce:keyword><ce:text>4]benzodiazepine-6-)one 4-DAMP</ce:text>
<ce:keyword><ce:text>4-diphenylacetoxy-<ce:italic>N</ce:italic>
-methyl piperidine methiodide DFP diisopropylfluorophosphate</ce:text>
</ce:keyword>
</ce:keyword>
</ce:keywords>
</head>
</converted-article>
</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo><title>5-HT3 receptors and cytotoxic drug-induced vomiting</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA"><title>5-HT</title>
</titleInfo>
<name type="personal"><namePart type="given">J.R.</namePart>
<namePart type="family">Fozard</namePart>
<affiliation>Merrell Dow Research Institute, 16 Rue d'Ankara, 67084 Strasbourg Cedex, France</affiliation>
<description>Present address: Preclinical Research Department, Sandoz AG, CH4002, Basel, Switzerland.</description>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="brief-communication" displayLabel="Short communication"></genre>
<originInfo><publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">1987</dateIssued>
<copyrightDate encoding="w3cdtf">1987</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<physicalDescription><internetMediaType>text/html</internetMediaType>
</physicalDescription>
<note type="content">Section title: Current awareness</note>
<subject><genre>Abbreviations</genre>
<topic>NMS : N-methylscopolamine AF-DX 116(11[[2-[(diethylamino)methyl]-1-piperidinyljacetyl]-5</topic>
<topic>11-dihydro-6H-pyrido[2</topic>
<topic>3–6][1</topic>
<topic>4]benzodiazepine-6-)one 4-DAMP : 4-diphenylacetoxy- N -methyl piperidine methiodide DFP diisopropylfluorophosphate</topic>
</subject>
<relatedItem type="host"><titleInfo><title>Trends in Pharmacological Sciences</title>
</titleInfo>
<titleInfo type="abbreviated"><title>TIPS</title>
</titleInfo>
<genre type="journal">journal</genre>
<originInfo><dateIssued encoding="w3cdtf">198702</dateIssued>
</originInfo>
<identifier type="ISSN">0165-6147</identifier>
<identifier type="PII">S0165-6147(00)X0133-2</identifier>
<part><date>198702</date>
<detail type="volume"><number>8</number>
<caption>vol.</caption>
</detail>
<detail type="issue"><number>2</number>
<caption>no.</caption>
</detail>
<extent unit="issue pages"><start>41</start>
<end>76</end>
</extent>
<extent unit="pages"><start>44</start>
<end>45</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">8AD96E6AC773C72735A7E56CF389FBA851203ECC</identifier>
<identifier type="DOI">10.1016/0165-6147(87)90002-2</identifier>
<identifier type="PII">0165-6147(87)90002-2</identifier>
<recordInfo><recordContentSource>ELSEVIER</recordContentSource>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Istex/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000102 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000102 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:8AD96E6AC773C72735A7E56CF389FBA851203ECC
   |texte=   5-HT3 receptors and cytotoxic drug-induced vomiting
}}

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration)

5-HT3 receptors and cytotoxic drug-induced vomiting

5-HT3 receptors and cytotoxic drug-induced vomiting

Source :

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri